In its 29 July 2025 announcement, AuMEGA Metals Ltd (ASX: AAM | TSXV: AUM | OTCQB: AUMMF) delivered a substantial exploration update covering three major Canadian projects—Cape Ray, Bunker Hill, and Hermitage. With a fully funded program and a strong C$9.2 million treasury, AuMEGA is aggressively expanding its data-driven strategy across Newfoundland’s Cape Ray Shear Zone, Canada’s largest known gold-bearing structure.

Alterity Therapeutics Limited (ASX: ATH; NASDAQ: ATHE) has announced highly promising topline results from its open-label Phase 2 clinical trial (ATH434-202) evaluating ATH434 in patients with advanced Multiple System Atrophy (MSA). The findings reinforce the company’s position as a front-runner in developing disease-modifying therapies for neurodegenerative diseases.

Actinogen Medical Ltd (ASX: ACW) has announced a significant milestone in the development of its lead candidate, Xanamem®(emestedastat), with the 100th participant now enrolled in its pivotal XanaMIA Phase 2b/3 Alzheimer’s disease trial. This event formally triggers the timeline for an independent interim analysis of safety and efficacy, bringing the company one step closer to potentially introducing a novel oral therapy for Alzheimer’s disease (AD).

Investing in emerging markets offers exciting opportunities for growth and diversification. These markets, often characterized by rapid economic development and increasing integration into the global economy, can provide higher returns compared to developed markets. However, they also come with unique risks and challenges. This article explores some of the most promising emerging investment markets worldwide, highlighting key sectors, trends, and practical tips for investors.

Australia is a country rich in natural resources and investment opportunities. With its vast landscapes and diverse economy, it provides a compelling environment for both domestic and international investors. In this blog post, we will explore the various resources available in Australia and how they impact investment opportunities across the nation.

Great Boulder Resources Ltd (ASX:GBR) is moving confidently into the second half of 2025. In the span of just two weeks, the Company has expanded the mineralised footprint at Side Well, announced significant new gold intersections at Ironbark, and secured $12.5 million in funding to accelerate its exploration strategy.

Coffee with Samso Episode 207 is all about a company that is feeling left behind in the midst of a unprecedented gold price rush. Gold miners, the producing companies on the ASX, are all buoyant and experiencing an emotional high on valuation. Shareholders are in a state of euphoria but in the rush, there are always some hidden value. The hidden value that is typically brushed aside by the juggernaut of cash producing gold miners speeding past the sights of investors.

Cyclone Metals Limited (ASX: CLE) has released its Quarterly Activities Report for the period ending 30 June 2025, and the momentum behind the Iron Bear Project is evident. Backed by a strategic partnership with Vale S.A., the quarter saw the completion of critical technical studies, advancement in metallurgical testing, progress across engineering and environmental baselines, and tangible steps toward the upcoming Scoping Study and PFS.

The Strategic Importance of Bauxite: Powering the Future of Aluminium - How Do ASX Investors take a Position in the Bauxite Business. The new cold war that is gaining momentum globally is fast creating vast opportunities for jurisdiction hosting commodity projects that have an inelastic demand. Commodities that fall into a real critical supply shortage are all getting a rejuvenation that has been is now making headlines. Commodities such as bauxite are now starting to get

AML3D Limited (ASX: AL3) continues to solidify its reputation as a key enabler of defence manufacturing transformation. Over the June 2025 quarter, the company advanced its “US Scale Up” strategy with concrete progress in strategic partnerships, facility expansion, and order momentum. With a freshly announced order for a portable ARCEMY® system and a strong quarterly cash position of A$30.4 million, AML3D is not just building metal parts, but reshaping how defence manufacturi

Proteomics International Laboratories Ltd (ASX: PIQ), a recognised pioneer in precision diagnostics, has announced a significant development for the Western Australian scientific and medical landscape: a $6 million funding boost to expand the WA Proteomics Facility. This strategic investment will be delivered over three years, with contributions from the WA State Government, Bioplatforms Australia, the University of Western Australia (UWA), and Proteomics International itself

Ausgold Limited (ASX: AUC) has delivered a definitive milestone with the release of its Definitive Feasibility Study (DFS) for the 100%-owned Katanning Gold Project (KGP). The study validates KGP as one of Australia’s most advanced undeveloped open-pit gold projects, combining scale, near-term development potential, and robust economics within a Tier-1 jurisdiction